France vs Netherlands: Proportion of isolates with decreased susceptibility or resistance
France
0
in 2018
Netherlands
0
in 2018
France rank
15th
Netherlands rank
15th
Proportion of isolates with decreased susceptibility or resistance over time
- France
- Netherlands
How they compare
France currently reports 0 against 0 in Netherlands, a difference of 0.
The two have swapped places 5 times across 10 shared years of data; in 2009 it was France ahead.
France ranks 15th and Netherlands ranks 15th of 27 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.92 | 0.8772 | 1.05 | France |
| 2010s | 1.11 | 0.6065 | 0.5058 | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, France or Netherlands?
- France, at 0 against 0 in Netherlands as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between France and Netherlands?
- 0, with France ahead.
- How many years of comparable data are there for France and Netherlands?
- 10 years are reported by both, from 2009 to 2018.
- How do France and Netherlands rank globally for proportion of isolates with decreased susceptibility or resistance?
- France ranks 15th and Netherlands ranks 15th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.